KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BeOne Medicines (ONC) Debt Ratio (2016 - 2025)

BeOne Medicines (ONC) has disclosed Debt Ratio for 11 consecutive years, with 0.15 as the latest value for Q2 2025.

  • On a quarterly basis, Debt Ratio changed N/A to 0.15 in Q2 2025 year-over-year; TTM through Jun 2025 was 0.15, a N/A change, with the full-year FY2024 number at 0.17, up 319.04% from a year prior.
  • Debt Ratio was 0.15 for Q2 2025 at BeOne Medicines, down from 0.17 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.17 in Q4 2024 to a low of 0.04 in Q4 2023.
  • A 5-year average of 0.1 and a median of 0.08 in 2021 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: plummeted 37.38% in 2023, then surged 319.04% in 2024.
  • BeOne Medicines' Debt Ratio stood at 0.07 in 2021, then fell by 11.18% to 0.07 in 2022, then tumbled by 37.38% to 0.04 in 2023, then skyrocketed by 319.04% to 0.17 in 2024, then dropped by 11.86% to 0.15 in 2025.
  • Per Business Quant, the three most recent readings for ONC's Debt Ratio are 0.15 (Q2 2025), 0.17 (Q4 2024), and 0.15 (Q1 2024).